CLARAVIS LD Trademark

Trademark Overview

On Friday, May 27, 2022, a trademark application was filed for CLARAVIS LD with the United States Patent and Trademark Office. The USPTO has given the CLARAVIS LD trademark a serial number of 97432567. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Thursday, November 21, 2024. This trademark is owned by BARR Laboratories, Inc.. The CLARAVIS LD trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, dermatological pharmaceutical preparations

General Information

Serial Number97432567
Word MarkCLARAVIS LD
Filing DateFriday, May 27, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateThursday, November 21, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 18, 2023

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, dermatological pharmaceutical preparations
NOT AVAILABLE"LD"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, June 3, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBARR Laboratories, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054
Party NameBARR Laboratories, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressParsippany, NJ 07054

Trademark Events

Event DateEvent Description
Tuesday, May 31, 2022NEW APPLICATION ENTERED
Friday, June 3, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, March 15, 2023ASSIGNED TO EXAMINER
Wednesday, March 15, 2023EXAMINERS AMENDMENT -WRITTEN
Wednesday, March 15, 2023EXAMINERS AMENDMENT E-MAILED
Wednesday, March 15, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, March 15, 2023EXAMINER'S AMENDMENT ENTERED
Wednesday, March 15, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 29, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 18, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, December 12, 2023SOU TEAS EXTENSION RECEIVED
Tuesday, December 12, 2023SOU EXTENSION 1 FILED
Tuesday, December 12, 2023SOU EXTENSION 1 GRANTED
Thursday, December 14, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 10, 2024SOU TEAS EXTENSION RECEIVED
Monday, June 10, 2024SOU EXTENSION 2 FILED
Monday, June 10, 2024SOU EXTENSION 2 GRANTED
Thursday, June 13, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 21, 2024SOU TEAS EXTENSION RECEIVED
Thursday, November 21, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, November 21, 2024SOU EXTENSION 3 FILED
Thursday, November 21, 2024SOU EXTENSION 3 GRANTED

Related Keywords

claravis pharmaceutical preparations dermatological namely